NDC 70518-4511-00 - Cephalexin

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
70518-4511
Requested NDC
70518-4511-00
Package NDCs from labels
70518-4511-0, 70518-4511-00
Manufacturer
REMEDYREPACK INC.
Effective date
2026-10-29
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
Cephalexin - REMEDYREPACK INC.REMEDYREPACK INC.2026-10-29HUMAN PRESCRIPTION DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
70518-4511-0Cephalexin100 mL in 1 BOTTLEFOR SUSPENSION1001

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 39 · 778 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
CephalexinCEPHALEXINREMEDYREPACK INC.2506895d-f3e0-4be9-95cb-7a6fd44de46d2026-11-06Warnings, Adverse reactionsExact identifier
unii: OBN7UDS42Y
BEVERHILL HAIR TONICUNDARIA PINNATIFIDA EXTRACT, CAMELLIA SINENSIS LEAF EXTRACT, MORUS ALBA BARK EXTRACT, PINUS DENSIFLORA LEAF EXTRACT, ARTEMISIA VULGARIS EXTRACT, SESAMUM INDICUM SEED EXTRACT, SODIUM BENZOATEBIOHERB Co., Ltd.32733977-606e-f110-e063-6294a90aba8f2026-11-06WarningsExact identifier
unii: OJ245FE5EU
CephalexinCEPHALEXINREMEDYREPACK INC.9fc5cfb0-7ba0-4669-b79c-270b6a9ff5732026-10-29Warnings, Adverse reactionsExact identifier
application number: ANDA210221
ndc (package): 70518-4511-0
ndc (product): 70518-4511
ndc11 (package): 70518451100
rxcui: 309113
spl id: 5efb88af-7cc8-0f30-e063-6294a90a71f1
spl set id: 9fc5cfb0-7ba0-4669-b79c-270b6a9ff573
unii: OBN7UDS42Y
CephalexinCEPHALEXINNuCare Pharmaceuticals,Inc.681c235f-6dee-1401-e053-2991aa0addc02026-10-28Warnings, Adverse reactionsExact identifier
unii: OBN7UDS42Y
CephalexinCEPHALEXINREMEDYREPACK INC.c0ca008e-0e28-412e-a58f-70f63817713b2026-10-23Warnings, Adverse reactionsExact identifier
unii: OBN7UDS42Y
CephalexinCEPHALEXINA-S Medication Solutions7cbdfa7f-2ea0-48e1-b506-59f58e5685a62026-10-19Warnings, Adverse reactionsExact identifier
unii: OBN7UDS42Y
CephalexinCEPHALEXINA-S Medication Solutions73920373-b45d-45d6-b183-d962467dde362026-10-19Warnings, Adverse reactionsExact identifier
unii: OBN7UDS42Y
CephalexinCEPHALEXINAscend Laboratories, LLC36882c6d-7b6f-41e3-8c54-e3b0073b8c072026-10-16Warnings, Adverse reactionsExact identifier
unii: OBN7UDS42Y
CephalexinCEPHALEXINNorthwind Health Company, LLC4ecf9314-76e2-c270-e063-6294a90ad8db2026-10-16Warnings, Adverse reactionsExact identifier
unii: OBN7UDS42Y
CephalexinCEPHALEXINREMEDYREPACK INC.8499aa5a-49b1-4555-bd27-6177d92b261d2026-10-15Warnings, Adverse reactionsExact identifier
unii: OBN7UDS42Y
CephalexinCEPHALEXINREMEDYREPACK INC.b3bb8222-161e-4d9c-8e08-7e22ad65bf722026-10-13Warnings, Adverse reactionsExact identifier
unii: OBN7UDS42Y
CephalexinCEPHALEXINREMEDYREPACK INC.b73593ce-0b1f-4371-bae1-140742de3b422026-10-12Warnings, Adverse reactionsExact identifier
unii: OBN7UDS42Y
CephalexinCEPHALEXINAscend Laboratories, LLCbb28751c-bd1b-4e7f-8271-a14c1b4314e32026-10-12Warnings, Adverse reactionsExact identifier
application number: ANDA210221
ndc (product): 67877-545
rxcui: 309110
rxcui: 309113
spl id: baa87916-ee88-4fe3-bf77-44a89859b203
spl set id: bb28751c-bd1b-4e7f-8271-a14c1b4314e3
unii: OBN7UDS42Y
Lymph Tonic IIECHINACEA (ANGUSTIFOLIA), COLLINSONIA CANADENSIS, PHYTOLACCA DECANDRA, KALI IODATUM, PINUS SYLVESTRIS, PIX LIQUIDA, FERRUM PHOSPHORICUM, AESCULUS HIPPOCASTANUM, BARYTA CARBONICA, BERBERIS VULGARIS, CALCAREA CARBONICA, CALCAREA PHOSPHORICA, CAUSTICUM, HEPAR SULPHURIS CALCAREUM, KREOSOTUM, LYCOPODIUM CLAVATUM, MERCURIUS SOLUBILIS, NATRUM MURIATICUM, NITRICUM ACIDUM, PHOSPHORUS, PULSATILLA (PRATENSIS), SILICEA, STELLARIA MEDIA, SULPHUR, TEREBINTHINA, THUJA OCCIDENTALIS, BUFO RANABioActive Nutritional, Inc.0e3265b0-b210-4a4c-80d2-8a9712981d4e2026-09-17WarningsExact identifier
unii: ETJ7Z6XBU4
CephalexinCEPHALEXINAurobindo Pharma Limitedf957ea27-2906-40c7-ac03-eb2f742473a02026-09-15Warnings, Adverse reactionsExact identifier
unii: OBN7UDS42Y
CephalexinCEPHALEXINAurobindo Pharma Limited8e28f049-6110-4473-830f-c494191a71972026-09-15Warnings, Adverse reactionsExact identifier
unii: OBN7UDS42Y
CephalexinCEPHALEXINPD-Rx Pharmaceuticals, Inc.e54df878-c235-4aa3-af33-fe5287c731382026-09-14Warnings, Adverse reactionsExact identifier
unii: OBN7UDS42Y
CephalexinCEPHALEXINPD-Rx Pharmaceuticals, Inc.1716ea1e-40a9-4a23-870b-3c7e3d0700952026-09-14Warnings, Adverse reactionsExact identifier
unii: OBN7UDS42Y
CephalexinCEPHALEXINNuCare Pharmaceuticals,Inc.6c543819-ab98-1dcd-e053-2991aa0a109d2026-09-14Warnings, Adverse reactionsExact identifier
unii: OBN7UDS42Y
Psoriasis ControlCENTELLA ASIATICA, SODIUM CHLORIDE, AND SILICON DIOXIDEForces of Nature2db33771-0bb9-49f8-84fa-dddc28e4ba262026-09-04WarningsExact identifier
unii: ETJ7Z6XBU4

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.